Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction
Qin Jiang, … , Chen Zhao, Biao Yan
Qin Jiang, … , Chen Zhao, Biao Yan
Published April 28, 2020
Citation Information: J Clin Invest. 2020;130(7):3833-3847. https://doi.org/10.1172/JCI123353.
View: Text | PDF
Research Article Ophthalmology

Circular RNA-ZNF532 regulates diabetes-induced retinal pericyte degeneration and vascular dysfunction

  • Text
  • PDF
Abstract

Diabetic retinopathy (DR) is the leading cause of blindness in working-age adults. Vascular pericyte degeneration is the predominant clinical manifestation of DR, yet the mechanism governing pericyte degeneration is poorly understood. Circular RNAs (circRNAs) play important roles in multiple biological processes and disease progression. Here, we investigated the role of circRNA in pericyte biology and diabetes-induced retinal vascular dysfunction. cZNF532 expression was upregulated in pericytes under diabetic stress, in the retinal vessels of a diabetic murine model, and in the vitreous humor of diabetic patients. cZNF532 silencing reduced the viability, proliferation, and differentiation of pericytes and suppressed the recruitment of pericytes toward endothelial cells in vitro. cZNF532 regulated pericyte biology by acting as a miR-29a-3p sponge and inducing increased expression of NG2, LOXL2, and CDK2. Knockdown of cZNF532 or overexpression of miR-29a-3p aggravated streptozotocin-induced retinal pericyte degeneration and vascular dysfunction. By contrast, overexpression of cZNF532 or inhibition of miR-29a-3p ameliorated human diabetic vitreous–induced retinal pericyte degeneration and vascular dysfunction. Collectively, these data identify a circRNA-mediated mechanism that coordinates pericyte biology and vascular homeostasis in DR. Induction of cZNF532 or antagonism of miR-29a-3p is an exploitable therapeutic approach for the treatment of DR.

Authors

Qin Jiang, Chang Liu, Chao-Peng Li, Shan-Shan Xu, Mu-Di Yao, Hui-Min Ge, Ya-Nan Sun, Xiu-Miao Li, Shu-Jie Zhang, Kun Shan, Bai-Hui Liu, Jin Yao, Chen Zhao, Biao Yan

×

Figure 4

Conditional knockdown of cZNF532 in pericytes induces retinal vascular dysfunction in vivo.

Options: View larger image (or click on image) Download as PowerPoint
Conditional knockdown of cZNF532 in pericytes induces retinal vascular d...
(A and B) Pericyte coverage was quantified by staining the whole-mount retinas with Isolectin IB4 and NG2 in nondiabetic C57BL/6 Cre mice (Cre) or diabetic Cre mice (Cre-DR) without or with intravitreous injection of Scr shRNA or cZNF532 shRNA after 1, 2, 4, or 6 months of treatment (n = 8; scale bar: 100 μm). Tile scanning and Adobe Photoshop were used to generate the composite images of a whole leaf of retinal vessels. The statistical result and representative images after 6 months of treatment are shown. (C and D) The mice were infused with EB dye for 2 hours. The tile-scanning images of whole retinal vessels were taken using a ×4 lens with identical gain settings. The statistical result of EB extravasation and representative images of flat-mounted retinas after 6 months of treatment (n = 8; scale bar, 500 μm). The red fluorescence indicates EB signal. The blood glucose levels of diabetic mice were above 300 mg/dL. All significant differences were evaluated by Mann-Whitney U test or Kruskal-Wallis test followed by Bonferroni’s post hoc test. Error bar indicates SD. *P < 0.05 compared with Cre group. #P < 0.05 among the marked groups.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts